What can the periodontal community learn from the pathophysiology of rheumatoid arthritis?

Journal of Clinical Periodontology

Volumn 38, Issue SUPPL. 11, 2011, Pages 106-113

  Culshaw, Shauna ^a   McInnes, Iain B ^b   Liew, Foo Y ^b  

^a GLASGOW DENTAL HOSPITAL AND SCHOOL   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Bone destruction; Host response; Periodontitis; Rheumatoid arthritis

Indexed keywords

AUTACOID; CYTOKINE; IMMUNOSUPPRESSIVE AGENT;

AUTOIMMUNE DISEASE; CONFERENCE PAPER; HUMAN; IMMUNOLOGY; LEUKOCYTE; PATHOPHYSIOLOGY; PERIODONTITIS; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS;

ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; CYTOKINES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION MEDIATORS; LEUKOCYTES; PERIODONTITIS; T-LYMPHOCYTES, REGULATORY;

EID: 79951897523     PISSN: 03036979     EISSN: 1600051X     Source Type: Journal    
DOI: 10.1111/j.1600-051X.2010.01669.x     Document Type: Conference Paper

References (75)

1. AAP Position Paper. (1999) Position paper: tobacco use and the periodontal patient. Journal of Periodontology 70, 1419-1427.
2. Abbink, J. J., Kamp, A. M., Nuijens, J. H., Swaak, T. J. & Hack, C. E. (1993) Proteolytic inactivation of alpha 1-antitrypsin and alpha 1-antichymotrypsin by neutrophils in arthritic joints. Arthritis & Rheumatism 36, 168-180. (Pubitemid 23059327)
3. Arend, W. P., Palmer, G. & Gabay, C. (2008) IL-1, IL- 18, and IL-33 families of cytokines. Immunological Reviews 223, 20-38.
4. Baka, Z., Buzas, E. & Nagy, G. (2009) Rheumatoid arthritis and smoking: putting the pieces together. Arthritis Research and Therapy 11, 238.
5. Bartok, B. & Firestein, G. S. (2010) Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunological Reviews 233, 233-255.
6. Baslund, B., Tvede, N., Danneskiold-Samsoe, B., Larsson, P., Panayi, G., Petersen, J., Petersen, L. J., Beurskens, F. J., Schuurman, J., van de Winkel, J. G., Parren, P. W., Gracie, J. A., Jongbloed, S., Liew, F. Y. & McInnes, I. B. (2005) Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study. Arthritis & Rheumatism 52, 2686-2692. (Pubitemid 41369096)
7. Brennan, F. M., Chantry, D., Jackson, A., Maini, R. & Feldmann, M. (1989) Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 2, 244-247. (Pubitemid 19180612)
8. Brennan, F. M. & McInnes, I. B. (2008) Evidence that cytokines play a role in rheumatoid arthritis. The Journal of Clinical Investigation 118, 3537-3545.
9. Breuil, V. & Euller-Ziegler, L. (2006) Bisphosphonate therapy in rheumatoid arthritis. Joint Bone Spine 73, 349-354.
10. Colmegna, I. & Alberts-Grill, N. (2009) Parvovirus B19: its role in chronic arthritis. Rheumatic Disease Clinic of North America 35, 95-110.
11. Costenbader, K. H. & Karlson, E. W. (2006) Epstein- Barr virus and rheumatoid arthritis: is there a link? Arthritis Research and Therapy 8, 204.
12. Di Paola, R., Mazzon, E., Muia, C., Crisafulli, C., Terrana, D., Greco, S., Britti, D., Santori, D., Oteri, G., Cordasco, G. & Cuzzocrea, S. (2007) Effects of etanercept, a tumour necrosis factor-alpha antagonist, in an experimental model of periodontitis in rats. British Journal of Pharmacology 150, 286-297. (Pubitemid 46221038)
13. Dorner, T. & Lipsky, P. E. (2006) Signalling pathways in B cells: implications for autoimmunity. Current Topics in Microbiology and Immunology 305, 213-240. (Pubitemid 47400260)
14. Drexler, S. K. & Foxwell, B. M. (2010) The role of toll-like receptors in chronic inflammation. International Journal of Biochemistry & Cell Biology 42, 506-518.
15. Edwards, J. C., Szczepanski, L., Szechinski, J., Filipowicz- Sosnowska, A., Emery, P., Close, D. R., Stevens, R. M. & Shaw, T. (2004) Efficacy of B-cell- targeted therapy with rituximab in patients with rheumatoid arthritis. New England Journal of Medicine 350, 2572-2581. (Pubitemid 38758544)
16. Edwards, S. W. & Hallett, M. B. (1997) Seeing the wood for the trees: the forgotten role of neutrophils in rheumatoid arthritis. Immunology Today 18, 320-324. (Pubitemid 27314467)
17. Ehrenstein, M. R., Evans, J. G., Singh, A., Moore, S., Warnes, G., Isenberg, D. A. & Mauri, C. (2004) Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. Journal of Experimental Medicine 200, 277-285. (Pubitemid 39031247)
18. Elliott, M. J., Maini, R. N., Feldmann, M., Kalden, J. R., Antoni, C., Smolen, J. S., Leeb, B., Breedveld, F. C., Macfarlane, J. D., Bijl, J. A. & Woody, J. N. (1994) Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor [alpha] (cA2) versus placebo in rheumatoid arthritis. The Lancet 344, 1105-1110. (Pubitemid 24317629)
19. Emery, P., Roy, F., Anna, F.-S., Joy, S., Leszek, S., Arthur, K., Artur, J. R., Ronald, F. v. V., Nicole, F. L., Sunil, A., Eva, W. H., Timothy, M. S. & Group, D. S. (2006) The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial. Arthritis & Rheumatism 54, 1390-1400.
20. Firestein, G. S. (2003) Evolving concepts of rheumatoid arthritis. Nature 423, 356-361.
21. Furst, D. E., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Burmester, G. R., Bijlsma, J. W., Dougados, M., Emery, P., Keystone, E. C., Klareskog, L. & Mease, P. J. (2005) Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin- 1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005. Annals of the Rheumatic Diseases 64 (Suppl. 4), iv2-iv14.
22. Genovese, M. C., Becker, J. C., Schiff, M., Luggen, M., Sherrer, Y., Kremer, J., Birbara, C., Box, J., Natarajan, K., Nuamah, I., Li, T., Aranda, R., Hagerty, D. T. & Dougados, M. (2005) Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition. New England Journal of Medicine 353, 1114-1123. (Pubitemid 41317434)
23. Genovese, M. C., Van den Bosch, F., Roberson, S. A., Bojin, S., Biagini, I. M., Ryan, P. & Sloan-Lancaster, J. (2010) LY2439821, a humanized antiinterleukin- 17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I randomized, double-blind, placebo-controlled, proof-of-concept study. Arthritis & Rheumatism 62, 929-939.
24. Goekoop-Ruiterman, Y. P., de Vries-Bouwstra, J. K., Allaart, C. F., van Zeben, D., Kerstens, P. J., Hazes, J. M., Zwinderman, A. H., Ronday, H. K., Han, K. H., Westedt, M. L., Gerards, A. H., van Groenendael, J. H., Lems, W. F., van Krugten, M. V., Breedveld, F. C. & Dijkmans, B. A. (2008) Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis & Rheumatism 58, S126-S135.
25. Grootveld, M., Henderson, E. B., Farrell, A., Blake, D. R., Parkes, H. G. & Haycock, P. (1991) Oxidative damage to hyaluronate and glucose in synovial fluid during exercise of the inflamed rheumatoid joint. Detection of abnormal low-molecular-mass metabolites by proton-n.m.r. spectroscopy. Biochemical Journal 273 (Part 2), 459-467.
26. Hasturk, H., Kantarci, A., Goguet-Surmenian, E., Blackwood, A., Andry, C., Serhan, C. N. & Van Dyke, T. E. (2007) Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo. Journal of Immunology 179, 7021-7029.
27. Hueber, A. J., Asquith, D. L., Miller, A. M., Reilly, J., Kerr, S., Leipe, J., Melendez, A. J. & McInnes, I. B. (2010) Mast cells express IL-17A in rheumatoid arthritis synovium. Journal of Immunology 184, 3336-3340.
28. Jazayeri, J. A., Carroll, G. J. & Vernallis, A. B. (2010) Interleukin-6 subfamily cytokines and rheumatoid arthritis: role of antagonists. International Immunopharmacology 10, 1-8.
29. Jimenez-Boj, E., Redlich, K., Turk, B., Hanslik-Schnabel, B., Wanivenhaus, A., Chott, A., Smolen, J. S. & Schett, G. (2005) Interaction between synovial inflammatory tissue and bone marrow in rheumatoid arthritis. Journal of Immunology 175, 2579-2588. (Pubitemid 41113871)
30. Jin, Q., Cirelli, J. A., Park, C. H., Sugai, J. V., Taba, M. Jr., Kostenuik, P. J. & Giannobile, W. V. (2007) RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis. Journal of Periodontology 78, 1300-1308.
31. Joosten, L. A., Netea, M. G., Kim, S. H., Yoon, D. Y., Oppers-Walgreen, B., Radstake, T. R., Barrera, P., van de Loo, F. A., Dinarello, C. A. & van den Berg, W. B. (2006) IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proceedings of the National Academy of Sciences of the United States of America 103, 3298-3303. (Pubitemid 43346464)
32. Kallberg, H., Padyukov, L., Plenge, R. M., Ronnelid, J., Gregersen, P. K., van der Helm-van Mil, A. H., Toes, R. E., Huizinga, T. W., Klareskog, L. & Alfredsson, L. (2007) Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis. American Journal of Human Genetics 80, 867-875. (Pubitemid 46668455)
33. Keystone, E. C. (2003) Abandoned therapies and unpublished trials in rheumatoid arthritis. Current Opinion in Rheumatology 15, 253-258.
34. Klareskog, L., Lorentzen, J., Padyukov, L. & Alfredsson, L. (2002) Genes and environment in arthritis: can RA be prevented? Arthritis Research 4 (Suppl. 3), S31-S36.
35. Klareskog, L., Ronnelid, J., Lundberg, K., Padyukov, L. & Alfredsson, L. (2008) Immunity to citrullinated proteins in rheumatoid arthritis. Annual Review of Immunology 26, 651-675. (Pubitemid 351600388)
36. Kremer, J. M., Genant, H. K., Moreland, L. W., Russell, A. S., Emery, P., Abud-Mendoza, C., Szechinski, J., Li, T., Ge, Z., Becker, J. C. & Westhovens, R. (2006) Effects of abatacept in patients with methotrexate- resistant active rheumatoid arthritis: a randomized trial. Annals of Internal Medicine 144, 865-876. (Pubitemid 46768126)
37. Kuhn, A. & Luger, T. A. (2010) Psoriasis: is ustekinumab superior to etanercept for psoriasis? Nature Reviews Rheumatology 6, 500-501.
38. Lefevre, S., Knedla, A., Tennie, C., Kampmann, A., Wunrau, C., Dinser, R., Korb, A., Schnaker, E. M., Tarner, I. H., Robbins, P. D., Evans, C. H., Sturz, H., Steinmeyer, J., Gay, S., Scholmerich, J., Pap, T., Muller-Ladner, U. & Neumann, E. (2009) Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Natural Medicines 15, 1414-1420.
39. Lewiecki, E. M. (2009) Denosumab update. Current Opinion in Rheumatology 21, 369-373.
40. Liew, F. Y., Pitman, N. I. & McInnes, I. B. (2010) Disease-associated functions of IL-33: the new kid in the IL-1 family. Nature Reviews Immunology 10, 103-110.
41. Lubberts, E., Koenders, M. I. & van den Berg, W. B. (2005) The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Research and Therapy 7, 29-37.
42. Mayer, Y., Balbir-Gurman, A. & Machtei, E. E. (2009) Anti-tumor necrosis factor-alpha therapy and periodontal parameters in patients with rheumatoid arthritis. Journal of Periodontology 80, 1414-1420.
43. McInnes, I. B., al-Mughales, J., Field, M., Leung, B. P., Huang, F. P., Dixon, R., Sturrock, R. D., Wilkinson, P. C. & Liew, F. Y. (1996) The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Natural Medicines 2, 175-182.
44. McInnes, I. B., Leung, B. P. & Liew, F. Y. (2000) Cell-cell interactions in synovitis. Interactions between T lymphocytes and synovial cells. Arthritis & Research 2, 374-378.
45. McInnes, I. B., Leung, B. P., Sturrock, R. D., Field, M. & Liew, F. Y. (1997) Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis. Natural Medicines 3, 189-195. (Pubitemid 27064704)
46. McInnes, I. B. & Schett, G. (2007) Cytokines in the pathogenesis of rheumatoid arthritis. Nature Reviews Immunology 7, 429-442. (Pubitemid 46834849)
47. McKellar, G. E., McCarey, D. W., Sattar, N. & McInnes, I. B. (2009) Role for TNF in atherosclerosis? Lessons from autoimmune disease. Nat Rev Cardiol 6, 410-417.
48. Miossec, P., Korn, T. & Kuchroo, V. K. (2009) Interleukin-17 and type 17 helper T cells. New England Journal of Medicine 361, 888-898.
49. Mohr, W., Westerhellweg, H. & Wessinghage, D. (1981) Polymorphonuclear granulocytes in rheumatic tissue destruction. III. an electron microscopic study of PMNs at the pannus-cartilage junction in rheumatoid arthritis. Annals of the Rheumatic Diseases 40, 396-399.
50. Nakae, S., Saijo, S., Horai, R., Sudo, K., Mori, S. & Iwakura, Y. (2003) IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proceedings of the National Academy of Sciences of the United States of America 100, 5986-5990. (Pubitemid 36576918)
51. Nesbitt, A., Fossati, G., Bergin, M., Stephens, P., Stephens, S., Foulkes, R., Brown, D., Robinson, M. & Bourne, T. (2007) Mechanism of action of certolizumab pegol (CDP870): in vitro comparison with other anti-tumor necrosis factor alpha agents. Inflammatory Bowel Diseases 13, 1323-1332. (Pubitemid 350206841)
52. Oates, T. W., Graves, D. T. & Cochran, D. L. (2002) Clinical, radiographic and biochemical assessment of IL-1/TNF-α antagonist inhibition of bone loss in experimental periodontitis. Journal of Clinical Periodontology 29, 137-143. (Pubitemid 41697746)
53. Ortiz, P., Bissada, N. F., Palomo, L., Han, Y. W., Al- Zahrani, M. S., Panneerselvam, A. & Askari, A. (2009) Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors. Journal of Periodontology 80, 535-540.
54. Pers, J. O., Saraux, A., Pierre, R. & Youinou, P. (2008) Anti-TNF-alpha immunotherapy is associated with increased gingival inflammation without clinical attachment loss in subjects with rheumatoid arthritis. Journal of Periodontology 79, 1645-1651.
55. Plant, D., Flynn, E., Mbarek, H., Dieude, P., Cornelis, F., Arlestig, L., Dahlqvist, S. R., Goulielmos, G., Boumpas, D. T., Sidiropoulos, P., Johansen, J. S., Ornbjerg, L. M., Hetland, M. L., Klareskog, L., Filer, A., Buckley, C. D., Raza, K., Witte, T., Schmidt, R. E. & Worthington, J. (2009) Investigation of potential non-HLA rheumatoid arthritis susceptibility loci in a European cohort increases the evidence for nine markers. Annals of the Rheumatic Diseases 69, 1548-1553.
56. Raza, K., Falciani, F., Curnow, S. J., Ross, E. J., Lee, C. Y., Akbar, A. N., Lord, J. M., Gordon, C., Buckley, C. D. & Salmon, M. (2005) Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Research and Therapy 7, R784-R795.
57. Reddy, M. S., Geurs, N. C. & Gunsolley, J. C. (2003) Periodontal host modulation with antiproteinase, anti-inflammatory, and bone-sparing agents. A systematic review. Annals of Periodontology 8, 12-37.
58. Rudnicka, W., Burakowski, T., Warnawin, E., Jastrzebska, M., Bik, M., Kontny, E., Chorazy-Massalska, M., Radzikowska, A., Buler, M., Maldyk, P. & Maslinski, W. (2009) Functional TLR9 modulates bone marrow B cells from rheumatoid arthritis patients. European Journal of Immunology 39, 1211-1220.
59. Sandborn, W. J. & Targan, S. R. (2002) Biologic therapy of inflammatory bowel disease. Gastroenterology 122, 1592-1608. (Pubitemid 34533555)
60. Santos, L. L., Morand, E. F., Hutchinson, P., Boyce, N. W. & Holdsworth, S. R. (1997) Anti-neutrophil monoclonal antibody therapy inhibits the development of adjuvant arthritis. Clinical and Experimental Immunology 107, 248-253. (Pubitemid 27049249)
61. Scheinecker, C., Redlich, K. & Smolen, J. S. (2008) Cytokines as therapeutic targets: advances and limitations. Immunity 28, 440-444. (Pubitemid 351467046)
62. Schett, G., Hayer, S., Zwerina, J., Redlich, K. & Smolen, J. S. (2005) Mechanisms of disease: the link between RANKL and arthritic bone disease. Nature Clinical Practice Rheumatology 1, 47-54.
63. Smolen, J. S., Aletaha, D., Koeller, M., Weisman, M. H. & Emery, P. (2007) New therapies for treatment of rheumatoid arthritis. Lancet 370, 1861-1874. (Pubitemid 350180008)
64. Smolen, J. S., Beaulieu, A., Rubbert-Roth, A., Ramos- Remus, C., Rovensky, J., Alecock, E., Woodworth, T. & Alten, R. (2008) Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double- blind, placebo-controlled, randomised trial. The Lancet 371, 987-997. (Pubitemid 351392039)
65. Stahl, E. A., Raychaudhuri, S., Remmers, E. F., Xie, G., Eyre, S., Thomson, B. P., Li, Y., Kurreeman, F. A., Zhernakova, A., Hinks, A., Guiducci, C., Chen, R., Alfredsson, L., Amos, C. I., Ardlie, K. G., Barton, A., Bowes, J., Brouwer, E., Burtt, N. P., Catanese, J. J., Coblyn, J., Coenen, M. J., Costenbader, K. H., Criswell, L. A., Crusius, J. B., Cui, J., de Bakker, P. I., De Jager, P. L., Ding, B., Emery, P., Flynn, E., Harrison, P., Hocking, L. J., Huizinga, T. W., Kastner, D. L., Ke, X., Lee, A. T., Liu, X., Martin, P., Morgan, A. W., Padyukov, L., Posthumus, M. D., Radstake, T. R., Reid, D. M., Seielstad, M., Seldin, M. F., Shadick, N. A., Steer, S., Tak, P. P., Thomson, W., van der Helm-van Mil, A. H., van der Horst-Bruinsma, I. E., van der Schoot, C. E., van Riel, P. L., Weinblatt, M. E., Wilson, A. G., Wolbink, G. J., Wordsworth, B. P., Wijmenga, C., Karlson, E. W., Toes, R. E., de Vries, N., Begovich, A. B., Worthington, J., Siminovitch, K. A., Gregersen, P. K., Klareskog, L. & Plenge, R. M. (2010) Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nature Genetics 42, 508-514.
66. Tak, P., Bacchi, M. & Bertolino, M. (2006) Pharmacokinetics of IL-18 binding protein in healthy volunteers and subjects with rheumatoid arthritis or plaque psoriasis. European Journal of Drug Metabolism and Pharmacokinetics 31, 109-116. (Pubitemid 44166289)
67. Takemura, S., Braun, A., Crowson, C., Kurtin, P. J., Cofield, R. H., O'Fallon, W. M., Goronzy, J. J. & Weyand, C. M. (2001) Lymphoid neogenesis in rheumatoid synovitis. Journal of Immunology 167, 1072-1080. (Pubitemid 32660867)
68. Toh, M. L., Kawashima, M., Hot, A. & Miossec, P. (2010) Role of IL-17 in the Th1 systemic defects in rheumatoid arthritis through selective IL-12Rbeta2 inhibition. Annals of the Rheumatic Diseases 69, 1562-1567.
69. van den Berg, W. B. & Miossec, P. (2009) IL-17 as a future therapeutic target for rheumatoid arthritis. Nature Reviews Rheumatology 5, 549-553.
70. van der Helm-van Mil, A. H., Wesoly, J. Z. & Huizinga, T. W. (2005) Understanding the genetic contribution to rheumatoid arthritis. Current Opinion in Rheumatology 17, 299-304. (Pubitemid 40616576)
71. Van Dyke, T. E. (2007) Control of inflammation and periodontitis. Periodontology 2000 45, 158-166.
72. Xu, Z.-Z., Zhang, L., Liu, T., Park, J. Y., Berta, T., Yang, R., Serhan, C. N. & Ji, R.-R. (2010) Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. Natural Medicines 16, 592-597.
73. Yen-Chun, G. L., Ulf, H. L. & Yen-Tung, A. T. (2010) Cytokine responses against periodontal infection: protective and destructive roles. Periodontology 2000 52, 163-206.
74. Yu, J. J., Ruddy, M. J., Wong, G. C., Sfintescu, C., Baker, P. J., Smith, J. B., Evans, R. T. & Gaffen, S. L. (2007) An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL- 17 receptor-dependent signals. Blood 109, 3794-3802. (Pubitemid 46641730)
75. + T cells in vivo by IL-15. Immunity 8, 591-599.